-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
Serine -X- _ O
proteases -X- _ O
act -X- _ O
through -X- _ O
the -X- _ O
proteolytic -X- _ O
cleavage -X- _ O
of -X- _ O
the -X- _ O
hemagglutinin -X- _ O
( -X- _ O
HA -X- _ O
) -X- _ O
of -X- _ O
influenza -X- _ O
viruses -X- _ O
for -X- _ O
the -X- _ O
entry -X- _ O
of -X- _ O
influenza -X- _ O
virus -X- _ O
into -X- _ O
cells -X- _ O
, -X- _ O
resulting -X- _ O
in -X- _ O
infection. -X- _ O
However -X- _ O
, -X- _ O
the -X- _ O
inhibitory -X- _ O
effects -X- _ O
of -X- _ O
serine -X- _ B-Intervention
protease -X- _ I-Intervention
inhibitors -X- _ I-Intervention
on -X- _ O
influenza -X- _ O
virus -X- _ O
infection -X- _ O
of -X- _ O
human -X- _ O
airway -X- _ O
epithelial -X- _ O
cells -X- _ O
, -X- _ O
and -X- _ O
on -X- _ O
their -X- _ O
production -X- _ O
of -X- _ O
inflammatory -X- _ O
cytokines -X- _ O
are -X- _ O
unclear. -X- _ O
METHODS -X- _ O
: -X- _ O
Primary -X- _ B-Patient
cultures -X- _ I-Patient
of -X- _ I-Patient
human -X- _ I-Patient
tracheal -X- _ I-Patient
epithelial -X- _ I-Patient
cells -X- _ I-Patient
were -X- _ O
treated -X- _ O
with -X- _ O
four -X- _ O
types -X- _ O
of -X- _ O
serine -X- _ B-Intervention
protease -X- _ I-Intervention
inhibitors -X- _ I-Intervention
, -X- _ I-Intervention
including -X- _ I-Intervention
camostat -X- _ I-Intervention
, -X- _ O
and -X- _ O
infected -X- _ O
with -X- _ O
A -X- _ O
/ -X- _ O
Sendai-H -X- _ O
/ -X- _ O
108 -X- _ O
/ -X- _ O
2009 -X- _ O
/ -X- _ O
( -X- _ O
H1N1 -X- _ O
) -X- _ O
pdm09 -X- _ O
or -X- _ O
A -X- _ O
/ -X- _ O
New -X- _ O
York -X- _ O
/ -X- _ O
55 -X- _ O
/ -X- _ O
2004 -X- _ O
( -X- _ O
H3N2 -X- _ O
) -X- _ O
. -X- _ O
RESULTS -X- _ O
: -X- _ O
Camostat -X- _ B-Outcome
reduced -X- _ I-Outcome
the -X- _ I-Outcome
amounts -X- _ I-Outcome
of -X- _ I-Outcome
influenza -X- _ I-Outcome
viruses -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
supernatants -X- _ I-Outcome
and -X- _ I-Outcome
viral -X- _ I-Outcome
RNA -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
cells. -X- _ I-Outcome
It -X- _ I-Outcome
reduced -X- _ I-Outcome
the -X- _ I-Outcome
cleavage -X- _ I-Outcome
of -X- _ I-Outcome
an -X- _ I-Outcome
influenza -X- _ I-Outcome
virus -X- _ I-Outcome
precursor -X- _ I-Outcome
protein -X- _ I-Outcome
, -X- _ I-Outcome
HA0 -X- _ I-Outcome
, -X- _ I-Outcome
into -X- _ I-Outcome
the -X- _ I-Outcome
subunit -X- _ I-Outcome
HA1. -X- _ I-Outcome
Camostat -X- _ I-Outcome
also -X- _ I-Outcome
reduced -X- _ I-Outcome
the -X- _ I-Outcome
concentrations -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
cytokines -X- _ I-Outcome
interleukin -X- _ I-Outcome
( -X- _ I-Outcome
IL -X- _ I-Outcome
) -X- _ I-Outcome
-6 -X- _ I-Outcome
and -X- _ I-Outcome
tumor -X- _ I-Outcome
necrosis -X- _ I-Outcome
factor -X- _ I-Outcome
( -X- _ I-Outcome
TNF -X- _ I-Outcome
) -X- _ I-Outcome
-α -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
supernatants. -X- _ I-Outcome
Gabexate -X- _ I-Outcome
and -X- _ I-Outcome
aprotinin -X- _ I-Outcome
reduced -X- _ I-Outcome
the -X- _ I-Outcome
viral -X- _ I-Outcome
titers -X- _ I-Outcome
and -X- _ I-Outcome
RNA -X- _ I-Outcome
levels -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
cells -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
aprotinin -X- _ I-Outcome
reduced -X- _ I-Outcome
the -X- _ I-Outcome
concentrations -X- _ I-Outcome
of -X- _ I-Outcome
TNF-α -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
supernatants. -X- _ I-Outcome
The -X- _ I-Outcome
proteases -X- _ I-Outcome
transmembrane -X- _ I-Outcome
protease -X- _ I-Outcome
serine -X- _ I-Outcome
S1 -X- _ I-Outcome
member -X- _ I-Outcome
( -X- _ I-Outcome
TMPRSS -X- _ I-Outcome
) -X- _ I-Outcome
2 -X- _ I-Outcome
and -X- _ I-Outcome
HAT -X- _ I-Outcome
( -X- _ I-Outcome
human -X- _ I-Outcome
trypsin-like -X- _ I-Outcome
protease -X- _ I-Outcome
: -X- _ I-Outcome
TMPRSS11D -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
which -X- _ I-Outcome
are -X- _ I-Outcome
known -X- _ I-Outcome
to -X- _ I-Outcome
cleave -X- _ I-Outcome
HA0 -X- _ I-Outcome
and -X- _ I-Outcome
to -X- _ I-Outcome
activate -X- _ I-Outcome
the -X- _ I-Outcome
virus -X- _ I-Outcome
, -X- _ I-Outcome
were -X- _ I-Outcome
detected -X- _ I-Outcome
at -X- _ I-Outcome
the -X- _ I-Outcome
cell -X- _ I-Outcome
membrane -X- _ I-Outcome
and -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
cytoplasm. -X- _ I-Outcome
mRNA -X- _ I-Outcome
encoding -X- _ I-Outcome
TMPRSS2 -X- _ I-Outcome
, -X- _ I-Outcome
TMPRSS4 -X- _ I-Outcome
and -X- _ I-Outcome
TMPRSS11D -X- _ I-Outcome
was -X- _ I-Outcome
detectable -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
cells -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
the -X- _ I-Outcome
expression -X- _ I-Outcome
levels -X- _ I-Outcome
were -X- _ I-Outcome
not -X- _ I-Outcome
affected -X- _ I-Outcome
by -X- _ I-Outcome
camostat. -X- _ I-Outcome
CONCLUSIONS -X- _ O
: -X- _ O
These -X- _ O
findings -X- _ O
suggest -X- _ O
that -X- _ O
human -X- _ O
airway -X- _ O
epithelial -X- _ O
cells -X- _ O
express -X- _ O
these -X- _ O
serine -X- _ O
proteases -X- _ O
and -X- _ O
that -X- _ O
serine -X- _ O
protease -X- _ O
inhibitors -X- _ O
, -X- _ O
especially -X- _ O
camostat -X- _ O
, -X- _ O
may -X- _ O
reduce -X- _ O
influenza -X- _ O
viral -X- _ O
replication -X- _ O
and -X- _ O
the -X- _ O
resultant -X- _ O
production -X- _ O
of -X- _ O
inflammatory -X- _ O
cytokines -X- _ O
possibly -X- _ O
through -X- _ O
inhibition -X- _ O
of -X- _ O
activities -X- _ O
of -X- _ O
these -X- _ O
proteases -X- _ O
. -X- _ O

